SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-09-000007
Filing Date
2009-03-31
Accepted
2009-03-31 15:33:29
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a10k_123108.htm 10-K 1541393
2 SUBSIDIARIES ex_21.htm EX-21 3332
3 CONSENT ex_23-1.htm EX-23.1 3237
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 15836
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 15834
6 CEO-CFO CERTIFICATION ex_32.htm EX-32 7495
  Complete submission text file 0000318306-09-000007.txt   1588749
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 09718535
SIC: 2834 Pharmaceutical Preparations